FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC ...Middle East

The US Food and Drug Administration has granted accelerated approval for tepotinib for the treatment of adults with metastatic non–small cell lung cancer harboring MET exon 14 skipping alterations. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Grants MET Inhibitor Tepotinib Accelerated Approval for NSCLC )

Also on site :

• I Use This Solar-Powered Security Camera to Keep My Home Safe, and It's $24 Off for Prime Day
• Merck spends $10 billion for Verona, gaining access to its COPD medication
• Perris mayor tells residents to stay inside after reports of ICE activity